Remission is a beginning. What helps it last?

1 NOVEMBER 2026 · NUTRITION COLLECTION · FROM THE OCTOBER 31 ARISING

Remission is a beginning. What helps it last?

A strong result can open a door without telling us how far the path continues. The Arising's October 31 article on RESET for Remission describes an intensive program of nutrition and exercise for younger adults with type 2 diabetes. Its most useful next question is what happens after the closely supported months end.

What the trial found

RESET randomized 96 adults aged 18–45 with early-onset type 2 diabetes and obesity, not using insulin, across three English and Canadian centres. A supervised low-energy diet and exercise program was compared with usual care. At 24 weeks, remission occurred in 27 of 50 participants (54%) versus 2 of 46 (about 4%). The reported absolute difference was about 50 percentage points (95% confidence interval 33–64). [1]

Remission meant HbA1c below 6.5%, without glucose-lowering medication for at least 12 weeks. Participants knew their assignments; endpoint assessment was blinded. Missing outcomes counted as no remission. Eighty-six participants attended final assessments. At least one adverse event occurred in 43/50 versus 6/46, mainly early constipation, headache, dizziness or fatigue; no serious adverse events were reported. [1]

A program, not a slogan

The original article makes clear that this was an organized intervention, with an intensive phase followed by maintenance and clinical supervision. It should not be translated into “just eat less,” an instruction to stop medication, or a test of someone's character. The intervention included support that a headline can easily erase.

The 2022 published protocol specified adults within six years of diagnosis and a 24-week primary endpoint. It provides design context, not proof of results. [2] The trial did not include a diet-only comparison: the combined program's result cannot tell us how much benefit exercise added on its own.

Keep the horizon visible

Remission at six months is encouraging. It does not establish a permanent cure, fewer future cardiovascular events or longer life. This small, selected population also cannot stand in for everyone with diabetes. Longer follow-up and delivery outside research centres remain important questions.

The human reason to care is the possibility of changing a disease trajectory early. The practical research question is how to make a successful program sustainable, accessible and compatible with everyday life. Neither question requires pretending the uncertainty has disappeared. Intensive dietary programs and medication changes need clinical supervision.

Sources, dates and scope

[1] Dasgupta and colleagues. RESET for Remission results, The Lancet Regional Health – Americas, online October 1, 2026. This update checked the publisher's indexed abstract and funding summary; full results text, supplements and author disclosures were unavailable for this review. Funders listed: UK Medical Research Council, Canadian Institutes of Health Research and John R. McConnell Foundation. No full-text audit is claimed.

[2] Published trial protocol, September 21, 2022; ISRCTN15487120. The registry's current full record could not be retrieved in this review. The protocol is not the results paper.

Editorial source: The Arising, October 31, 2026, full feature 01, pages 7–9, “Low-Calorie Diet Plus Exercise Put 54% of Younger Diabetics in Remission.” That article relied on secondary coverage. This adaptation corrects its observational-study badge to randomized trial, and uses serious rather than severe for the results abstract's adverse-event wording. Original source preserved. This is an update to the nutrition collection, not a newly published full newsletter.